Optimization of NULOJIX (Belatacept) Usage as a Means of Minimizing CNI Exposure in Simultaneous Pancreas and Kidney Transplantation (CTOT-15)
收藏DataCite Commons2022-12-21 更新2025-04-16 收录
下载链接：
https://www.immport.org/shared/study/SDY1433
下载链接
链接失效反馈官方服务：
资源简介：
This study is a multicenter, prospective, randomized (1:1), open-label, Phase II study to compare a NULOJIX (belatacept) based immunosuppressive regimen to a CNI-based regimen in recipients of SPK. Subjects will be consented and enrolled until a total of 60 subjects are randomized.
提供机构：
ImmPort
创建时间：
2020-04-09
